Renditatug (BAT8008 Antibody) is an antibody targeting TROP2. Renditatug can be used for the synthesis of ADC BAT8008. The corresponding isotype control is: Human IgG1 kappa, Isotype Control [1] [2].
In Vitro, Renditatug is an ADC antibody targeting TROP2.
References:
[1]. Jianli Zhao et al. BAT8008, a TROP-2 antibody-drug conjugate (ADC), in patients with advanced solid tumor: Results from a phase 1 study.. J Clin Oncol 43, 3024-3024(2025).
In Vitro, Renditatug is an ADC antibody targeting TROP2.
References:
[1]. Jianli Zhao et al. BAT8008, a TROP-2 antibody-drug conjugate (ADC), in patients with advanced solid tumor: Results from a phase 1 study.. J Clin Oncol 43, 3024-3024(2025).